3 Canadian AI Healthcare Stocks With Market Caps Up To $316 Million

AI hardware just had a spotlight moment after Samsung projected a record quarterly operating profit of about $80b on the back of soaring demand for AI chips. That wave of spending on computing power needs software and data-driven tools that actually touch patients. Canadian AI healthcare stocks sit right at that junction. This article walks through three standouts from our screener that align with this theme.

The three stocks covered below are just a sample from this theme, and the full screen surfaced 2 more AI healthcare companies with equally compelling narratives that are not covered here. If you want to go straight to the source, use the Transformative Artificial intelligence (AI) Healthcare Stocks screener to identify, compare, and analyze the AI healthcare opportunities that best fit your own conviction level.

Telescope Innovations (CNSX:TELI)

Telescope Innovations is a Vancouver based chemical technology business that builds manufacturing processes and AI ready tools for pharmaceutical and chemical clients, with its DIRECTINJECT-LC system feeding data into AI models for drug discovery. It currently earns about CA$7.3 million from chemicals and has a market cap near CA$34 million.

AI driven healthcare research needs clean, continuous data from lab reactors, which is exactly where Telescope Innovations focuses with its DIRECTINJECT-LC ecosystem and collaboration on AI ready reactors with AGI Group. Investors get exposure to this lab infrastructure angle; however, the stock’s premium P/S multiple and short cash runway leave a lot riding on how one pressure around funding and commercial uptake plays out.

With that much riding on execution and funding, check the Telescope Innovations financial health report to see how Telescope Innovations’ balance sheet frames the risk reward trade off.

Profound Medical (TSX:PRN)

Profound Medical develops AI powered, MRI guided systems like TULSA PRO for incision free prostate ablation and Sonalleve for treating fibroids and other benign tumors. The business generated about $19 million from medical technology and carries a market value near CA$316 million.

Profound Medical provides direct exposure to AI controlled, MRI guided therapy where software steers heat in real time to spare healthy tissue. The appeal is clear for procedures that require precision and faster workflow. A key consideration is how hospitals may respond if one unresolved reimbursement factor changes adoption incentives.

If that changes, you will want the 1 key reward and 1 important warning sign so you can see how the risk and potential upside could quickly rebalance.

Perimeter Medical Imaging AI (TSXV:PINK)

Perimeter Medical Imaging AI sells OCT imaging systems and AI tools for real-time tissue margin assessment in the operating room, including Claire OCT with ImgAssist for breast-conserving surgery. The business generated about $2 million from medical imaging systems, all from Canada, and has a market cap near CA$35 million.

Perimeter Medical Imaging AI integrates AI directly into breast cancer surgery, with Claire OCT and ImgAssist giving surgeons real-time margin views instead of relying solely on lab pathology. Revenue remains small and the company is still reporting losses, so the outcome of its AI strategy is closely tied to factors such as funding conditions and the pace of hospital adoption.

With that adoption question hanging over Perimeter Medical Imaging AI, review the analysis report for Perimeter Medical Imaging AI to see what could accelerate or stall the next phase.

Seeking Fresh Alternatives Before Momentum Hits

Fresh breakouts rarely stay quiet for long. Momentum builds, prices start flying, and late entries get caught chasing. Scan these under the radar ideas while it matters and act now.

• Spot cash rich operators before the crowd by reviewing the curated list of solid balance sheet and fundamentals (7 results) that can better withstand shocks when sentiment drops.
• Target resilient cash payers by running through the hand picked 2 dividend fortresses that may keep income flowing even when prices swing.
• Ride the next automation wave earlier by checking the focused 88 robotics and automation stocks where select enablers of industrial and logistics upgrades are grouped for fast comparison.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com